Hypermethylation of E-Cadherin and Estrogen Receptor-α Gene Promoter and Its Association with Clinicopathological Features of Breast Cancer in Iranian Patients

Rasti, Mozhgan; Entezam, Mona; Monabati, Ahmad
September 2009
Iranian Journal of Medical Sciences;Sep2009, Vol. 34 Issue 3, p186
Academic Journal
Background: Aberrant methylation of cytosine-guanine dinucleotide islands leads to inactivation of tumor suppressor genes in breast cancer. Tumor suppressor genes are unmethylated in normal tissue and often become hypermethylated during tumor formation, leading to gene silencing. We investigated the association between E-cadherin (CDH1) and estrogen receptor-a (ESRa) gene promoter methylation and major clinical and pathological features of breast cancer in Iranian women. Methods: DNA was extracted from 67 primary breast tumors and gene promoter methylation was analyzed by methylationspecific polymerase chain reaction method. Results: Fifty percent of the samples showed aberrant methylation in at least one of the two tested loci. We detected CDH1 hypermethylation in 41% of invasive tumors and receptor- α gene hypermethylation in 18% of invasive tumor samples. We found no association between CDH1 and receptor- α gene hypermethylation (P=0.45). There was a correlation between hypermethylation of CDH1 locus and tumor size ⩾5 cm (P=0.019). Conclusion: Our data suggest that the malignant progression of human ductal and lobular breast carcinoma in Iranian women involves a heterogeneous pattern of cytosine-guanine dinucleotide island hypermethylation of the CDH1 gene.


Related Articles

  • Reference Materials for Calibration of Analytical Biases in Quantification of DNA Methylation. Yu, Hannah; Hahn, Yoonsoo; Yang, Inchul // PLoS ONE;9/14/2015, Vol. 10 Issue 9, p1 

    Most contemporary methods for the quantification of DNA methylation employ bisulfite conversion and PCR amplification. However, many reports have indicated that bisulfite-mediated PCR methodologies can result in inaccurate measurements of DNA methylation owing to amplification biases. To...

  • The correlation between DNMT1 and ERα expression and the methylation status of ERα, and its clinical significance in breast cancer. WEIJIE ZHANG; ZHIWEI CHANG; KE SHI; LIJIE SONG; LI CUI; ZHIJUN MA; XIANGKE LI; WANG MA; LIUXING WANG // Oncology Letters;Mar2016, Vol. 11 Issue 3, p1995 

    The correlation between the expression of DNA methyltransferase-1 (DNMT1) and estrogen receptor α (ERα), as well as the methylation status of ERα, was analyzed to investigate the clinical significance of DNMT1 and ERα in breast cancer. Substance P immunohistochemistry and reverse...

  • Retrospective protein expression and epigenetic inactivation studies of CDH1 in patients affected by low-grade glioma. D'Urso, Pietro; D'Urso, Oscar; Storelli, Carlo; Catapano, Giuseppe; Gianfreda, Cosimo; Montinaro, Antonio; Muscella, Antonella; Marsigliante, Santo // Journal of Neuro-Oncology;Aug2011, Vol. 104 Issue 1, p113 

    Aberrant methylation of CpG islands in the promoter regions of tumour cells results in loss of gene function. In addition to genetic lesions, changes in the methylation profile of the promoters may be considered a factor for tumour-specific aberrant expression of the genes.We investigated the...

  • Cloning, characterization and expression of estrogen receptor beta in the male half-smooth tongue sole, Cynoglossus semilaevis. Li, Wenge; Zhang, Jiaren; Mu, Weijie; Wen, Haishen // Fish Physiology & Biochemistry;Jun2013, Vol. 39 Issue 3, p671 

    A full-length sequence encoding the estrogen receptor beta was isolated from half-smooth tongue sole, Cynoglossus semilaevis (hstsERβ) using reverse transcription-polymerase chain reaction (RT-PCR) and rapid amplification of cDNA ends procedures. The hstsERβ cDNA clone was found to contain...

  • The mitochondrial ATPase6 gene is more susceptible to mutation than the ATPase8 gene in breast cancer patients. Ghaffarpour, Massoud; Mahdian, Reza; Fereidooni, Forouzandeh; Kamalidehghan, Behnam; Moazami, Nasrin; Houshmand, Massoud // Cancer Cell International;2014, Vol. 14 Issue 1, p1 

    Background Breast cancer is the most common malignancy in women throughout the world. Mitochondria play important roles in cellular energy production, free radical generation and apoptosis. Identification of mitochondrial DNA mutations and/or polymorphisms as cancer biomarkers is rapidly...

  • HYPERMETHYLATION OF THE TUMOR SUPPRESSOR RASSFIA GENE IN MALIGNANT AND BENIGN BREAST TISSUES FROM EGYPTIAN PATIENTS. Ali-Labid, Randa; Annos, Faten Abd El-Monem // Egyptian Journal of Biochemistry & Molecular Biology;Dec2009, Vol. 27 Issue 2, p83 

    Breast cancer is the leading cancer among females. There is a critical need for improved molecular biomarkers that are diagnostic, prognostic and also capable of predicting the progression of benign high-risk lesions to invasive carcinoma. RAS association domain family protein 1A (RASSF1A) gene,...

  • ID4 is frequently downregulated and partially hypermethylated in prostate cancer. Vinarskaja, Anna; Goering, Wolfgang; Ingenwerth, Marc; Schulz, Wolfgang // World Journal of Urology;Jun2012, Vol. 30 Issue 3, p319 

    Purpose: The candidate tumor suppressor ID4 is downregulated in various cancers by DNA hypermethylation. We have performed the first systematic analysis of ID4 expression and methylation in prostate cancer. Methods: ID4 mRNA expression was analyzed by quantitative RT-PCR in 47 carcinoma and 13...

  • TET2 promoter DNA methylation and expression analysis in pediatric B-cell acute lymphoblastic leukemia. Musialik, Ewa; Bujko, Mateusz; Wypych, Agnieszka; Matysiak, Michal; Siedlecki, Janusz Aleksander // Hematology Reports;2014, Vol. 6 Issue 1, p19 

    TET2 is a novel tumor suppressor gene involved in several hematological malignancies of myeloid and lymphoid origin. Besides loss-of-function mutations and deletions, hypermethylation of the CpG island at the TET2 promoter was found in human cancer. Previous analysis revealed no TET2 mutations...

  • Investigating the Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients with Breast Cancer. Tajadini, Mohammad Hassan; Khadem, Houra; Pourhosein, Meraj; Sabzghabaee, Ali Mohammad; Hemati, Simin; Sadeghi, Hamid Mirmohammad // Journal of Isfahan Medical School;Feb2013, Vol. 30 Issue 218, p2217 

    Background: Breast cancer is the most common cancer among women. Genetic is a proven risk factor in this disease. As breast cancer genes (BRCA1 and BRCA2) affect the incidence of this type of cancer, identification of mutation carriers is important in reduction of the overall risk. The purpose...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics